.jpg)
Founder/CEO, MS Biostatistics, LLC
MS Biostatistics, LLC, Clermont, FL, USA
Clermont, Florida, United States
Marc Schwartz is the Founder/CEO of MS Biostatistics, LLC, which he formed in 2018 with almost 40 years of experience in the healthcare industry, providing extensive expertise in clinical study design, data management, statistical analysis, and the interpretation of clinical information.
Marc's expertise has been primarily focused upon late phase observational and randomized studies, as well as serving as the independent biostatistician on data safety monitoring boards for phase II/III pharmaceutical clinical trials and investigational device exemption (IDE) medical device clinical trials.
He has collaborated with pharmaceutical and medical device industry sponsors, clinical research organizations (CROs), international, national, and regional medical and surgical specialty societies, and independent study investigators, across numerous medical and surgical specialty domains.
Some of these collaborative engagements included the development and software implementation of sophisticated, multivariable model-based, risk adjustment methods to estimate patient outcomes, enabling physicians to better assess their care, support continuous quality control initiatives, and communicate meaningful outcomes to the healthcare community.
His involvement with these clinical studies has contributed to the successful submission of well over 100 peer reviewed manuscripts, podium presentations and posters.
Marc is a member of the American Statistical Association, the Society for Clinical Trials, The R Foundation for Statistical Computing and has previously served on the editorial review board for The Journal Of Statistical Software.
AbbVie (Products/Services: No) (Contracted Research (Principal Investigators must provide information, even if received by the institution))
Thursday, November 10, 2022
4:14 PM – 4:30 PM
